Tag Archives: MA

Top 10 Heal Care Stocks To Own For 2018

Whether you’re ready for it or not, the marijuana industry is flowering before our eyes. In North America, cannabis research firm ArcView, in partnerships with BDS Analytics, has projected sales growth of 28% through 2021. If this estimate proves accurate, we could be looking at almost $25 billion in annual North American legal weed sales in just a few years.

All eyes are on Canada

Though the entire world has seemingly looked to the U.S. to lead the charge of cannabis progressivism, it’s stepped aside and allowed Canada to grab the reins. Despite 30 U.S. states having legalized marijuana in some capacity, the federal government and Attorney General Jeff Sessions have been unwavering on pot’s Schedule I classification — i.e., wholly illegal, prone to abuse, and having no recognized medical benefits.

Image source: Getty Images.

Top 10 Heal Care Stocks To Own For 2018: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested small cap manufacturing and 3D printing service provider ARC Group WorldWide (NASDAQ: ARCW) as a short trade:

Top 10 Heal Care Stocks To Own For 2018: Computer Programs and Systems Inc.(CPSI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Computer Programs & Systems, Inc. (NASDAQ: CPSI) were down 31 percent to $27.00 after the company posted weaker-than-expected Q2 results.

Top 10 Heal Care Stocks To Own For 2018: Uni-Pixel, Inc.(UNXL)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Uni-Pixel (UNXL) manufactures electronic film products using its proprietary manufacturing process, UniBoss. This stock closed up 7.6% to $16.84 in Monday’s trading session.

    Monday’s Volume: 1.88 million

    Three-Month Average Volume: 1 million

    Volume % Change: 108%

    From a technical perspective, UNXL bounced sharply higher here right off its 50-day moving average of $15.89 with above-average volume. This stock looks to be forming a double bottom chart pattern at $14.91 to $15.16. If that bottom holds, then shares of UNXL could see a continuation of Monday’s upside action.

    Traders should now look for long-biased trades in UNXL as long as it’s trending above $15.16 or $14.91 and then once it sustains a move or close above Monday’s high of $17.53 with volume that hits near or above 1 million shares. If we get that move soon, then UNXL will set up to re-test or possibly take out its next major overhead resistance level at its 200-day moving average of $19.89.

  • [By Lisa Levin]

    Shares of UniPixel Inc (NASDAQ: UNXL) were down 22 percent to $1.63 after the company announced a public offering of newly issued shares of stock. UniPixel plans to offer 5.35 million shares of its own stock at a public offering price of $1.50 per share with the option for its underwriters to purchase up to an additional 802,500 shares.

  • [By Peter Graham]

    Small cap sensor film stockUniPixel Inc (NASDAQ: UNXL) reportedQ1 2017 earnings after the Thursday market close withshares falling both on Thursday and in afterhours trading. UniPixel is not well covered or known by analysts yet and this can make shares volatile. However and last September, we had suggested a long position in the stock based upon technicals by saying:

Top 10 Heal Care Stocks To Own For 2018: Canon, Inc.(CAJ)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    Miscellaneous shorts. Lamensdorf is also betting against Japanese printer and camera giant Canon (CAJ) since he believes the company still hasn’t figured out a way to compete with smartphones.

  • [By Dan Carroll]

    Nikon’s story is similar to what’s plaguing its Japanese rival, Canon (NYSE: CAJ  ) . Canon’s stock has nosedived by 20% year to date, but the stock’s recovered nearly 3% over the past month. Don’t let appearances fool you: The company slashed its full-year sales and profit forecasts back in July, as the worldwide camera market has slumped, and as smartphones continue to take over this aging niche. Canon’s route back to respectability looks like a treacherous climb.

Top 10 Heal Care Stocks To Own For 2018: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Chris Lange]

    Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

  • [By Peter Graham]

    Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

Top 10 Heal Care Stocks To Own For 2018: Firsthand Technology Value Fund, Inc.(SVVC)

Advisors’ Opinion:

  • [By Hibah Yousuf]

    Similarly, Twitter is also the biggest holding in the Firsthand Technology Value Fund (SVVC). With just over 1 million shares of the social media platform, Twitter represents nearly 11% of the total portfolio as of mid-year. Shares of Firsthand Technology Value jumped more than 6% Friday.

Top 10 Heal Care Stocks To Own For 2018: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Helios and Matheson Analytics Inc. (Nasdaq: HMNY) is an information technology company that provides its clients predictive analytics. The company uses big data for most of its software and operates within the financial services, insurance, and healthcare industries. HMNY is up 278% YTD after it announced a strategic merger with a GPS application company, called RedZone Maps. RedZone is known for mapping crime in major cities. News of the merger sent HMNY climbing over 1,000% from $1.11 per share to $13.75 per share over the course of a week. The stock has since fallen to $5.23 per share as of Monday intraday.

  • [By Paul Ausick]

    The subscription service is controlled by Helios & Matheson Analytics Inc. (NASDAQ: HMNY), which owns about 81% of MoviePass stock.

    MoviePass CEO Mitch Lowe commented:

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Peter Graham]

    Small cap analytics stock Helios and Matheson Analytics (NASDAQ: HMNY) is thethird most shorted stock on the NASDAQ with short interest of 54.30% according to Highshortinterest.com. Helios and Matheson Analytics is a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology. The Company owns a majority interest in MoviePass Inc., the nation’s premier movie-theater subscription service.Other holdings include RedZone Map, a safety and navigation app for iOS and Android users, and a community-based ecosystem that features a socially empowered safety map app that enhances mobile GPS navigation using advanced proprietary technology.

  • [By Lisa Levin]

    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares dropped 32 percent to $6.87 after the company reported a common stock offering. The size of the offering was not disclosed. The company said that proceeds from the offering and warrants will be used to increase the company’s ownership stake in MoviePass.

Top 10 Heal Care Stocks To Own For 2018: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Visa Inc. (NYSE:V) and MasterCard (NYSE:MA) aren’t the only two players in the credit card and electronic payments space, but they are the biggest and best-known. Both Visa and MasterCard have extended their reach across the globe, and both have high expectations in their trajectories for future growth. Yet after a big push in the stock market that has sent both of these financial stocks to all-time highs, investors need to know which of the two leaders in the card industry is more deserving of their attention. Let’s take a closer look at Visa and MasterCard, comparing them using several different metrics to see which company’s shares are the better buy.

  • [By Matthew Cochrane]

    Keeping these statistics in mind, one can see how marrying these two concepts would be equivalent to finding the Holy Grail of payments. This is how Mastercard Inc (NYSE:MA), clearly one of the giants in the payments space, plans to capture market share and win more card issuer deals by making payments as safe and frictionless as possible.

  • [By John Ballard]

    Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

  • [By ]

    Card networks Visa (NYSE: V) and Mastercard (NYSE: MA), which benefit from the same tailwinds, aren’t much better, both with minuscule yields of 0.7%.

  • [By ]

    Mastercard Inc. (MA) announced this week that it plans to employ new blockchain specialists in an upcoming hiring round of 175 technology developers, Coindesk reported. The new tech hires will work from Mastercard’s Ireland office, where its research and development business, Mastercard Labs, is headquartered. The company said the aim of the new hires is to further the development of more efficient payment systems. Last September, Mastercard filed a patent for a blockchain system recording purchase orders, invoices and transaction data. Then in November, the company filed another application for blockchain-based solutions aimed at increasing the speed of transaction settlements.

  • [By WWW.GURUFOCUS.COM]

    For the details of Night Owl Capital Management, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Night+Owl+Capital+Management%2C+LLC

    These are the top 5 holdings of Night Owl Capital Management, LLCVisa Inc (V) – 231,674 shares, 10.84% of the total portfolio. Shares reduced by 5.42%Mastercard Inc (MA) – 167,458 shares, 9.92% of the total portfolio. Shares reduced by 5.37%Alphabet Inc (GOOG) – 18,613 shares, 8.13% of the total portfolio. Shares reduced by 4.05%Amazon.com Inc (AMZN) – 15,674 shares, 7.32% of the total portfolio. Shares reduced by 3.17%The Priceline Group Inc (PCLN) – 6,970 shares,

Top 10 Heal Care Stocks To Own For 2018: Fox Factory Holding Corp.(FOXF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Fox Factory Holding Corp (NASDAQ: FOXF) was down 1.8 percent after posting a 2.16 percent rise over the day.

    Finally, Groupon Inc (NASDAQ: GRPN) gained 1.3 percent, continuing with the 3.85 percent spike it experienced on Friday trading.

Top 10 Heal Care Stocks To Own For 2018: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By Jim Robertson]

    Shares of small cap natural compound and Cannabinoid extract stock Radient Technologies (CVE: RTI) have been taking off lately as the Company makes further progress commercializing its technology. The Company extracts natural compounds from a range of biological materials using microwave assisted processing (MAP), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield and cost. This technology is based on the selective and localized heating of the moisture present in all natural materials using microwaves as the energy source. This gives the Company a technological advantage and expertise in selectively depositing microwave energy into different parts of a biomass’ complicated chemical system form the core of our extraction advantage.

  • [By Bryan Murphy]

    It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.

    Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.

    Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.

    To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.

    Using its patented MAP process, Radient is able to selectiv

  • [By James E. Brumley]

    Some of the stories about how cannabis has changed lives for the better are nothing less than astounding. Take Illinois resident Darren Miller as an example. In 2015 Miller was diagnosed with lung cancer that was later deemed terminal. Miller underwent chemotherapy, without much hope, but also began using high-THC Indica cannabis oil. Miller is alive today, and arguably shouldn’t be.

    Then there’s Floridian Branden Petro. Not only does Petro suffer epilepsy, he commonly experiences seizures stemming from the condition. Nothing has stopped the seizures as quickly or effectively as 200 milligram worth of THC cannabis oil, administered as a nasal spray. Within 20 seconds of using it, it’s as of the seizure never happened.

    And there are millions of other such (and less dramatic) examples, all pointing in the same direction – cannabis has medical value on multiple fronts. Not facilitating its commercialization is a wasted opportunity.

    It’s a notion that’s far from lost on the people that have built Canadian-based Radient Technologies Inc (CVE:RTI) from the round up, recently inking a deal with supplier of cannabinoid extracts, Aurora Cannabis.

    It’s a real accolade. Aurora is one of the largest licensed producers of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), and recently began construction on an unprecedented 800,000 square foot production facility in Leduc County, Alberta. This facility, known as “Aurora Sky”, is anticipated to be capable of producing in excess of 100,000 kg of high-quality, low-cost marijuana per year.

    In most regards though, Radient Technologies is the big winner of the deal, as the partnership is apt to put its high-tech facility in full demand, helping to advance the advent of cannabis in all its potential glory.

    It’s a rather amazing science, really. Radient Technologies uses an ingredient-extraction process called microwave assisted proc

Hot Tech Stocks For 2018

Spotify just added a new platform for its streaming services ahead of the Spotify IPO date…

According to an Aug. 4 TechCrunchreport, Microsoft Corp. (Nasdaq: MSFT) will add a Spotify app to the new Xbox One X, slated to debut this November.

Spotify has been available on rival PlayStation 4 since 2015, so why has it taken so long for Microsoft to add an app for the streaming service to its network?

MSFT offers its own music service, Groove Music, which launched in 2012.

According to TechCrunch, keeping Spotify out of its platform may not have significantly contributed to Grooves user growth. It could also cost Microsoft sales if users are deciding between an Xbox and a PlayStation.

Hot Tech Stocks For 2018: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday began on a down note for the stock market, as the Dow Jones Industrials fell back down below the 20,000 level. Major market benchmarks finished with losses of 0.6% to 0.8%, and some market commentators attributed the declines to nervousness about the Trump administration’s actions to clamp down on immigration. Others noted that the latest reading of U.S. economic growth showed a 1.9% rise in gross domestic product for the fourth quarter, finishing the year with an overall GDP increase of just 1.6%, down a full percentage point from 2015’s growth. Despite the overall sullen mood in the market, some stocks gained ground, and GoPro (NASDAQ:GPRO), Movado Group (NYSE:MOV), and IPG Photonics (NASDAQ:IPGP) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Hot Tech Stocks For 2018: Shopify Inc.(SHOP)

Advisors’ Opinion:

  • [By John Ballard]

    Less than 10% of retail sales in the U.S. take place online, and the worldwide retail market is estimated to be well over $20 trillion.These numbers spell big opportunity for top e-commerce companies like PayPal Holdings (NASDAQ:PYPL) and Shopify (NYSE:SHOP).

  • [By ]

    Shopify (NYSE: SHOP) is an ecommerce platform and hosting company providing the websites and tools for small businesses. The company and its customers might not have the financial capital for access to fast lanes in a post-neutral internet.

  • [By Brian Withers]

    If investors want to tap into the growing trend of e-commerce and diversify their portfolio beyond Amazon, Shopify (NYSE:SHOP) and Etsy (NASDAQ:ETSY) make the shortlist. Shopify is more a pick-and-shovelplay, as the company hasbuilt a powerful back office platform that essentially enables entrepreneursto run an e-commerce business from their phone. Etsy is a pure play marketplace that focuses on serving the creative entrepreneur. These two companies had similar revenue in 2016, were both started in almost the same year (Etsy 2005, Shopify 2006), and are in the business of helping product-selling entrepreneurs connect to buyers online. Let’s take a deeper dive into these two companies and see which is the better buy.

Hot Tech Stocks For 2018: Mitel Networks Corporation(MITL)

Advisors’ Opinion:

  • [By Lisa Levin]

    ShoreTel Inc (NASDAQ: SHOR) shares shot up 28 percent to $7.47. Mitel Networks Corp (NASDAQ: MITL) announced plans to acquire Shortel for $7.50 per share in cash.

Hot Tech Stocks For 2018: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Visa Inc. (NYSE:V) and MasterCard (NYSE:MA) aren’t the only two players in the credit card and electronic payments space, but they are the biggest and best-known. Both Visa and MasterCard have extended their reach across the globe, and both have high expectations in their trajectories for future growth. Yet after a big push in the stock market that has sent both of these financial stocks to all-time highs, investors need to know which of the two leaders in the card industry is more deserving of their attention. Let’s take a closer look at Visa and MasterCard, comparing them using several different metrics to see which company’s shares are the better buy.

  • [By Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan Wathen]

    In order to point you in the right direction, we asked a team of Fools to highlight a dividend stock that they feel is a great stock for a beginner. Read on to see why they picked AT&T (NYSE:T),Apple (NASDAQ:AAPL),Anheuser-Busch InBev(NYSE:BUD), Mastercard(NYSE:MA), andJPMorgan Chase(NYSE:JPM).

  • [By WWW.GURUFOCUS.COM]

    For the details of Night Owl Capital Management, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Night+Owl+Capital+Management%2C+LLC

    These are the top 5 holdings of Night Owl Capital Management, LLCVisa Inc (V) – 231,674 shares, 10.84% of the total portfolio. Shares reduced by 5.42%Mastercard Inc (MA) – 167,458 shares, 9.92% of the total portfolio. Shares reduced by 5.37%Alphabet Inc (GOOG) – 18,613 shares, 8.13% of the total portfolio. Shares reduced by 4.05%Amazon.com Inc (AMZN) – 15,674 shares, 7.32% of the total portfolio. Shares reduced by 3.17%The Priceline Group Inc (PCLN) – 6,970 shares,

Top 10 Medical Stocks To Invest In 2018

32 Great Insurance Jokes

Feds Officially Delay Obama-Era Group Disability Regs, a Little

Trump’s Short-Term Health Move May Get States Hopping

Depression is one of the insurance agent’s worst enemies.

This painful mental health disorder can affect the underwriting process for life insurance, disability insurance, and many other medically underwritten products.

Researchers at the Behavioral Risk Factor Surveillance System (BRFSS), an arm of the Centers for Disease Control and Prevention (CDC), recently posted a new batch of survey data that shows where depression hits the hardest.

(Related: Simple Medicine)

You can use the BRFSS portal system to see how depression is affecting different types of people in every state in the country. The federal government publishes the data free from copyright restrictions. That means you can extract data yourself and put the numbers in blog posts, social media posts, infographics or even ads.

Top 10 Medical Stocks To Invest In 2018: China Evergrande Group (EGRNF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

Top 10 Medical Stocks To Invest In 2018: Care.com, Inc.(CRCM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Care.com Inc (NYSE: CRCM) got a boost, shooting up 16 percent to $11.01 after the company reported upbeat quarterly results.

    MaxPoint Interactive Inc (NASDAQ: MXPT) shares were also up, gaining 19 percent to $5.44. MaxPoint Interactive reported Q4 earnings of $0.59 per share on revenue of $46.3 million.

Top 10 Medical Stocks To Invest In 2018: KeyCorp(KEY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    But then there was good news from rail transport company CSX (CSX ) , which saw growth in every one of its business lines. Foot Locker (FL) also surprised to the upside, sending shares up a quick 5.3%. Cramer fave and Action Alerts PLUS holding KeyCorp (KEY) also delivered, as did paint maker Sherwin-Williams (SHW) .

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said he noticed big options volume in the December weekly, 18 strike calls in KeyCorp (NYSE: KEY). He decided to follow the trade and he is going to hold the position for 1 to 2 days.

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Top 10 Medical Stocks To Invest In 2018: Mechel OAO(MTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By Lisa Levin]

    Basic materials shares climbed by 2.37 percent in trading on Wednesday. Meanwhile, top gainers in the sector included Handy & Harman Ltd (NYSE: HNH), and Mechel PAO (ADR) (NYSE: MTL).

  • [By Javier Hasse]

    Steel stocks are spiking on Monday afternoon, with AK Steel Holding Corporation (NYSE: AKS) up almost 7.5 percent, United States Steel Corporation (NYSE: X) up about 6.4 percent, Cliffs Natural Resources Inc (NYSE: CLF) up more than 1 percent and Mechel PAO (ADR) (NYSE: MTL) up 16.8 percent. The stocks are not being helped by a few analyst upgrades (although, surely not hurt by them), but seem to be mostly rallying on the back of Donald Trump’s election as president of the United States.

  • [By Shanthi Rexaline]

    Mechel PAO (ADR) (NYSE: MTL) is rallying strongly, rising to a three-year high on roughly 1.7 times its average volume.

    The stock has been on a tear in recent months. After dipping below the $2 level in late April and languishing in the sub-$2 range until August, the stock has nearly tripled in the run up to Monday’s session.

  • [By Lisa Levin]

    Basic materials shares gained around 1.89 percent in trading on Tuesday. Meanwhile, top gainers in the sector included Olympic Steel, Inc. (NASDAQ: ZEUS), and Mechel PAO (ADR) (NYSE: MTL).

Top 10 Medical Stocks To Invest In 2018: Sonoco Products Company(SON)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Deutsche Bank’s Debbie Jones and team contend that Sonoco’s (SON) sale of its plastic-container business to Australia’s Amcor is a sign that M&A is in the offing. They explain why:

    Sonoco announced (9/1) that it is selling its Rigid Plastics Blow Molding operations to Amcor (AMC.AU) for $280M. The transaction price represents a multiple of ~8.0x LTM EBITDA. The business had annual sales of ~$210M and consisted of six production sites in the US and one in Canada. Blow molding operations represented ~10% of Sonocos Consumer Packaging segment sales and EBITDA. The transaction is expected to close in Q4. We expect the proceeds to be used to for M&A focused in flexible packaging, thermoforming and temperature-assured packaging.

    We dont believe Sonoco considered its blow molding operations essential to its growth strategy. This standalone business is also more capital intensive compared to some of its other plastic packaging businesses and SON held a small position in the overall market. Ultimately, the company decided it wants to focus its capital in higher growth platforms. We do not expect the divestment to reduce resin buying scale for Sonoco’s remaining assets given different resin buying. Note that with the divestiture of blow molding and the Canton closures plant (divested in Feb. 2015), this makes the ~$100M reels business the last standalone business in the portfolio, but we do not expect this to be divested in the near-term unless cash is needed for much larger M&A.

    Shares of Sonoco have gained 1.3% to $52.49 at 2:12 p.m. today.

     

Top 10 Medical Stocks To Invest In 2018: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Monday afternoon, the basic materials shares surged 0.57 percent. Meanwhile, top gainers in the sector included CF Industries Holdings, Inc. (NYSE: CF), up 7 percent, and Intrepid Potash, Inc. (NYSE: IPI), up 7 percent.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

Top 10 Medical Stocks To Invest In 2018: Exxon Mobil Corporation(XOM)

Advisors’ Opinion:

  • [By Dustin Parrett]

    For comparison, Exxon Mobil Corp. (Nasdaq: XOM) is currently valued at $373.91 billion, making it the largest oil company in the United States. Aramco will be worth more than five times Exxon. In fact, Aramco will be worth more than the top “oil majors” of Exxon, Shell, BP, and Chevron combined.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded up about 1.23% at $85.77. The stock’s 52-week range is $73.55 to $95.55. Volume was about 15% above the daily average of around 11.1 million shares. The company had no specific news Friday.

  • [By Paul Ausick]

    Shares of Exxon Mobil Corp. (NYSE: XOM) dropped nearly 1% last week, to close down 10% for the year to date and keep its position as the worst performing of the 30 stocks included in the Dow Jones Industrial Average index. The DJIA has posted a gain of 4.2% so far this year.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage loss ahead of the close Thursday was Exxon Mobil Corp. (NYSE: XOM) which traded down about 1.94% at $84.61. The stock’s 52-week range is $72.61 to $95.55. Volume was about 15% above the daily average of around 11 million shares. The company had no specific news.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded down 1.59% at $81.21. The stock’s 52-week range is $80.76 to $95.55. Volume was about equal to the daily average of around 12 million shares. The company had no news, but the large increase in crude inventories really pounded both Exxon and Chevron this afternoon.

  • [By Craig Jones]

    Alan Knuckman of Bulls-Eye Option shared with the viewers of Bloomberg Markets his bullish trading idea in Exxon Mobil Corporation (NYSE: XOM).

    He said Exxon Mobil traded flat over the last year of trade, while Dow Jones gained 25 percent and he expects it's going to catch up.

Top 10 Medical Stocks To Invest In 2018: TransAlta Renewables Inc. (TRSWF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    TransAlta Renewables (OTC:TRSWF) (RNW CA) is a good comp, and trades at 12.3x EBITDA. Similar to NYLD, they own renewables as well as a few gas-fired power plants. The yield on RNW is similar to NYLD at 6.0%. The only real difference is that RNW is less levered (mid-3s on a debt/EBITDA basis), but has clearly overpaid for certain assets in order to help the parent (TransAlta Corp. ticker TA in Canada) to delever.

Top 10 Medical Stocks To Invest In 2018: Madrigal Pharmaceuticals, Inc. (MDGL)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Madrigal (MDGL) has a significant market opportunity to treat NASH. Its MGL-3196 is well positioned as a potential treatment when the illness is at its earliest stages of development, and thereby save the most lives and money.

  • [By Lisa Levin]

    Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) shares shot up 74 percent to $80.43 after the company disclosed that its MGL-3196 achieved primary endpoint in patients with biopsy-proven non-alcoholic steatohepatitis in Phase 2 clinical trial.

Top 10 Medical Stocks To Invest In 2018: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By ]

    We’re confident that this year’s list is poised to perform just as our previous picks — which is no small feat. We’ve bagged winners like the 64.3% return from Mastercard (NYSE: MA), 44.3% from Intel (Nasdaq: INTC), 38.9% from Deere (NYSE: DE) and even 101.8% from Skyworks Solutions (Nasdaq: SWKS).

  • [By John Ballard]

    Partnerships play a crucial role in extending PayPal’s reach to new customers and driving higher engagement. The deal with Visa(NYSE:V) opened the door for partnerships with Mastercard(NYSE:MA), Citigroup(NYSE:C), and Fidelity National Information Services (NYSE:FIS). As a result, more deals will come that will increase PayPal’s relevancy and ubiquity in the mobile payment landscape.

  • [By David Zeiler]

    Ethereum has plenty of real-world catalysts driving it already:

    It’s become the foundation of the booming ICO phenomenon, through which cryptocurrency-based startups have raised millions of dollars in a matter of minutes. Most new tokens are either based on Ethereum and/or require users to buy the cryptocurrency with Ethereum. It’s Turing complete, which means the Ethereum network can function as a giant, global computer. That’s what makes Ethereum an ideal platform for applications like smart contracts. And it’s enabled the creation of a new kind of app, “Dapps,” or distributed applications that run on the network. Businesses are adopting it. The 150-plus companies in the Enterprise Ethereum Alliance include some of the world’s biggest and most prestigious corporations, such as JPMorgan Chase & Co. (NYSE:JPM), Microsoft Corp. (Nasdaq: MSFT), Mastercard Inc. (NYSE: MA), and Deloitte.

    Related: What’s the Best Cryptocurrency to Invest in Today?

  • [By Matthew Cochrane]

    With this mindset, it is no wonder that PayPal finished 2016 on a wave of deal-making momentum. In the past 12 months, PayPal completed agreements with a number of financial and tech companies including Alibaba Group Holding Ltd (NYSE: BABA), Citigroup Inc (NYSE: C), Facebook Inc (NASDAQ: FB), Mastercard Inc (NYSE: MA), Visa Inc (NYSE: V), and Vodafone Group Plc (NASDAQ: VOD).

best stock buys now

Billionaire Mark Cuban said this weekend that AI will cause mass unemployment.

And soon.

Dallas Mavericks owner and billionaire businessman Mark Cuban

The “Shark Tank” star took to the stage at multimedia celeb festival OZY yesterday to warn that “however much change you saw over the past 10 years with the Apple (Nasdaq: AAPL) iPhone, that’s nothing. There’s going to be a lot of unemployed people replaced with technology and if we don’t start dealing with that now, we’re going to have some real problems.”

Indeed, in September 2016, business trends think tank Forrester Research released an exhaustive report anticipating that robots will eliminate 6% of all U.S. jobs by 2021 – 10% of which will occur in the retail industry alone.

best stock buys now: Western Union Company (The)(WU)

Advisors’ Opinion:

  • [By Brian Mathews]

    Western Union Co. (NYSE: WU) is the leading independent provider of consumer money transfer services. After a rough couple of years and dealing with compliance and regulatory issues, WU has finally weathered the storm. Market share has stabilized and revenues have been slowly growing. One of Western Union’s strengths is its size in the industry. The money-transfer business is highly scalable because the incremental costs of processing additional transactions are minimal. This allows WU to have operating margins that are twice as large as its closest competitor. Also, since WU is a highly recognizable brand, consumers flock to use its services in comparison to its peers. Western Union submitted a bid to buy the Australian company OzForex. If this deal goes through, it will provide additional scale to WU, especially to a market clientele that is more affluent. With the troubling times behind the company and expansion on the horizon, expect WU stock to appreciate to $24.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was The Western Union Co. (NYSE: WU) which jumped 3.6% to $20.28. The stocks 52-week range is $18.07 to $22.70. Volume was 11 million which is well above the daily average of around 5.8 million shares.

  • [By WWW.THESTREET.COM]

    You don’t need to be an expert technical trader to figure out the price action in shares of $10 billion payment services stock Western Union (WU) . Instead, the price action is more or less as simple as it gets. Since January, Western Union has been a “buy the dips stock”, bouncing its way higher in a well-defined uptrend. And shares are showing traders another buyable dip this week.

best stock buys now: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer’s game plan starts on Monday, with earnings from Del Taco Restaurants (TACO)  . Despite strong same-store sales last quarter, Cramer said he’s expecting a struggle this quarter.

  • [By Peter Graham]

    Small cap Mexican restaurant stock Del Taco Restaurants (NASDAQ: TACO) reported fiscal Q3 2017 earnings after the market closed on Thursday with earnings meeting Wall Street expectations plus the Company also revised its guidance for fiscal year 2017 on several key metrics. Total revenuerose 6.3% to$111.0 million driven by a 6.1% increase in Company restaurant sales and a 7.9% increase in franchise revenue. Comparable restaurant sales increased 4.1% system-wide for the fiscal third quarter 2017, resulting in a 10.8% increase on a two-year basis. The Del Taco system has now generated comparable restaurant sales growth for 16 consecutive quarters whileCompany-operated comparable restaurant sales increased 3.7% marking the 21st consecutive quarter of comparable restaurant sales growth. Franchise comparable restaurant sales increased 4.6%. Net income was $5.1 million versus$4.9 million. The CEO commented:

  • [By Lee Jackson]

    Del Taco Restaurants Inc. (NASDAQ: TACO) had a director at the company selling stock last week. The board member shed a total of 831,314 sharesat between $11.40 and $11.84 apiece. The total for the sale was $10 million. The shares ended the weekat $12.36, in a 52-week range of$8.43 to $15.32. The consensus price target is $17.07.

best stock buys now: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc performing better with Best Buy Co Inc (NYSE: BBY) being the big winner whilesmall caps hhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII) haveunderperformed, butare showing signs of improvement:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basically breaking even with Best Buy Co Inc (NYSE: BBY) all over the place (albeit it took off again last year) while small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both underperformed for over three years now:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basicallyabove break even with Best Buy Co Inc (NYSE: BBY)taking off againwhile small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both been sliding in recent years:

best stock buys now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

best stock buys now: Isle of Capri Casinos Inc.(ISLE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Isle of Capri Casinos (NASDAQ: ISLE) reported better-than-expected earnings for its fourth quarter on Tuesday.

    The company posted adjusted earnings of $0.62 per share on revenue of $264.9 million. However, analysts were expecting earnings of 0.54 per share on revenue of $266.8 million.

  • [By Lisa Levin]

    Isle of Capri Casinos (NASDAQ: ISLE) shares shot up 30 percent to $22.03. Eldorado Resorts, Inc. (NYSE: ERI) and Isle of Capri Casinos, Inc. struck a merger deal through which the former would buy the latter for $23 a share in cash or 1.638 shares.

  • [By Lee Jackson]

    Isle of Capri Casinos Inc. (NASDAQ: ISLE) had the president of the company selling some stock. Arnold Block parted with 63,648 shares of the gaming company at $26.20 per share. The total for the sale cameto $2 million. He was joined by CEO Eric Hausler and the chief legal officer, Edmund Quatmann, who together sold 163,949 shares forbetween $26.02 and $26.26. Their trades totaled $4 million.The shares closed on Friday at $25.45, so well-timed trades indeed.The 52-week trading range is $13.01 to $26.89, and the consensus price objective is $23.

best stock buys now: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan Wathen]

    In order to point you in the right direction, we asked a team of Fools to highlight a dividend stock that they feel is a great stock for a beginner. Read on to see why they picked AT&T (NYSE:T),Apple (NASDAQ:AAPL),Anheuser-Busch InBev(NYSE:BUD), Mastercard(NYSE:MA), andJPMorgan Chase(NYSE:JPM).

  • [By WWW.THESTREET.COM]

    This one could be the easiest of advances, both because credit losses are down big and because its credit-card brethren — Capital One Financial, Discover, Visa (V) and MasterCard (MA) — have all had significant rallies. I actually regard this stock as inexpensive and think it can be bought here now that it has fully absorbed the loss of the Costco (COST) business to Visa and Citigroup (C) .

  • [By WWW.GURUFOCUS.COM]

    For the details of Night Owl Capital Management, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Night+Owl+Capital+Management%2C+LLC

    These are the top 5 holdings of Night Owl Capital Management, LLCVisa Inc (V) – 231,674 shares, 10.84% of the total portfolio. Shares reduced by 5.42%Mastercard Inc (MA) – 167,458 shares, 9.92% of the total portfolio. Shares reduced by 5.37%Alphabet Inc (GOOG) – 18,613 shares, 8.13% of the total portfolio. Shares reduced by 4.05%Amazon.com Inc (AMZN) – 15,674 shares, 7.32% of the total portfolio. Shares reduced by 3.17%The Priceline Group Inc (PCLN) – 6,970 shares,

The 12.6 Percent Yield I Want To Collect In 2018

Last month, werevealedour Top 10 Stocks for 2018.

As you may know, this is one of our most successful annual research reports. It’s also perhaps the most important… this list lays out what we think are the most important traits to look for in a stock in order to be a successful investor over the long run.

—Sponsored Link—
Collect A Colossal Payday Thanks To California’s Legal Cannabis
We’ve already seen people accumulate massive gains from previous marijuana legalization announcements, but this event is about to blow the lid off of anything we’ve seen so far. Are you positioned to profit? One penny pot stock expert has narrowed his focus to three tiny California pot stocks expected to explode following legalization. With billions of dollars in revenue projected to flow into this industry, learning how to get in on the ground floor — before these tiny stocks shoot up — is your best shot at life-altering gains. Go here now.

We’re confident that this year’s list is poised to perform just as our previous picks — which is no small feat. We’ve bagged winners like the 64.3% return from Mastercard (NYSE: MA), 44.3% from Intel (Nasdaq: INTC), 38.9% from Deere (NYSE: DE) and even 101.8% from Skyworks Solutions (Nasdaq: SWKS).

In fact, if you had invested along with this report over the past three years, you would haveDOUBLED the stock market’s performance each year.

Some of the names you’ll see in this report are companies you’ve likely heard about before. But there are others, like the no. 2 pick I’m going to cover today, that I’d be surprised if one in 10 investors even know about.

But make no mistake, these stocks all have one common thread: We think each one has the potential to beat the Dow… the Nasdaq… and the S&P 500 in the coming year.

Of course, there aren’t any guarantees, but when you read the profile of each pick, it’s easy to see why we’re excited about this exclusive group of 10 investments. And if you’re still worried about market volatility, our no. 2 pick — and its almost unbelievable yield — could be exactly what your portfolio needs.

Top 10 Stock No. 2: The Blockbuster Money Machine
You dont find many opportunities like this one. It’s a company that collects revenue from on-screen advertising. But in a way that huge digital advertisers like Google and Facebook simply can’t touch.

Let me explain…

Huge advertisers like Google are highly complex and dominate their market. For instance, this year Google will collect $73.8 billion in advertising revenue. That’s one-third of all online advertising dollars worldwide.

Nobody comes even close to that. The next largest digital advertiser, Facebook, makes only half of what Google does. Both of these companies have unique websites that attract millions of viewers each day and expose them to each company’s advertising networks.

No other search engine can compete with Google. Just like no other social media site can compete with Facebook. Their main source of income — advertising — is secure.

And this is also the case with our Top 10 Stock #2, the largest U.S. theater advertising firm, National CineMedia (Nasdaq: NCMI). Altogether, CineMedia displays its ads on 19,900 movie screens in 49 of America’s 50 largest cities… exposing its ads to over 700 million moviegoers each year.

Unlike Google or Facebook, the company doesn’t have to maintain the venues that display its advertisements. This is a huge advantage when you consider that Google spends billions on running its search engines and maintaining its cloud servers. The equipment costs alone are enormous.

The secret to CineMedia’s success is that the company doesn’t have to own any of the theaters where its ads are displayed. Instead, it has relationships with the three largest theater chains, AMC, Cinemark and Regal, as well as with 30 regional theater networks.

In a recent quarter, Google generated $99 billion in revenue. But $11 billion of that went to buying and replacing equipment to do it. That’s 11% of revenue gobbled up for capital expenses. Compare that to CineMedia that only spends a tiny 3% of its revenues on capital expenses.

In fact, this company’s operating costs are so low, its income margins are 50% higher than Google’s. This creates huge cash flows that management can use to pay you the fat 12.6% annual dividend. Compare that to Facebook or Google — which don’t pay any dividends.

What I like most about CineMedia is that its cash flow is in a long-term uptrend, having grown 71% over the past two years.

This growing cash flow creates a built-in cushion to ensure our dividends keep growing. Aside from myTop Stock Advisorreaders, you’ll find very few private investors own this stock. In fact, less than 6% of all outstanding shares are owned by private investors.

The remaining 94% of CineMedia shares are owned by institutions that have done their homework, making NCMI one of the financial world’s best-kept secrets.

Get Your No-Risk Copy Of This Report Today
I have more details about National CineMedia in our Top 10 Stocks for 2018 report. In fact, I give you everything you need to know about this stock, as well as everything on all 10 of our 2018 stocks.

This includes our no. 3 stock, a company that’s returned 813% since 2008 — and is still going at 23% a year. Equally impressive is stock no. 5, which has grown same-store sales every year for 27 years, through every retail environment.

I’m not exaggerating when I say that these stocks are your best bet for building wealth in 2018 and beyond.

What’s more is that we’re offering this report for free. There’s absolutely no risk to you. All we ask is that you try a 90-day, no obligation trial membership to myTop Stock Advisornewsletter just to see if you like it. Even if you don’t, you can keep the report as a free gift.

Follow this link to learn more.